Filing Flows › Accendra Health (ACH) › Q3 2025
Accendra Health (ACH) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 31, 2025
Accendra Health (ACH) reported revenue of $697M for the third quarter 2025 (Q3 2025), +2% from a year earlier and +2% from the quarter before. Operating margin was 3.8%, net loss $150M (21.6% of revenue).
Accendra Health, Q3 2025: revenue $697M (+2% year over year), operating margin 3.8%, net loss $150M, operating cash flow −$173M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $697M | +2% | +2% |
| Operating profit | $26.5M | — | — |
| Net earnings | −$150M | — | — |
| Operating cash flow | −$173M | -559% | — |
What changed
Revenue was $697.3M in Q3 2025, up 2% year over year and up 2% from the previous quarter. Diabetes was the largest line at 29% of revenue. Sleep therapy added $8.6M year over year (up 5%), 83% of the total change. Wound care declined 7%.
Operating profit was $26.5M, a 3.8% margin (down 0.7 points year over year). Operating profit fell $4.6M even though revenue rose $10.4M versus a year earlier, so costs grew faster than sales. The quarter ended with a net loss of $150.3M, narrower than the previous quarter's $869.1M loss. Net interest and other expense of $174.8M was the main reason.
Operating cash flow was −$172.5M. Non-cash charges added back $64.1M of depreciation and amortization and $2.3M of share-based compensation. Working capital and other items used $88.7M. Capital expenditures of $54.2M exceeded it, leaving free cash flow of −$226.8M.
Questions
What was Accendra Health's revenue in the third quarter 2025?
Accendra Health (ACH) reported revenue of $697M for the third quarter 2025 (Q3 2025), +2% from a year earlier and +2% from the quarter before.
Was Accendra Health profitable in the third quarter 2025?
Operating profit was $26.5M (3.8% of revenue) and net loss $150M.
Source: Accendra Health 10-Q on SEC EDGAR.